Press Release

Clinical data validate pioneering MeMed BV technology improves diagnosis of pediatric patients with fever in the Emergency Department Bacterial and viral infections are often clinically indistinguishable, leading to inappropriate patient management and antibiotic misuse MeMed BV® is the first FDA-cleared host-immune response assay to accurately distinguish between the two in just 15 minutes PETAH TIKVA, Israel […]

DUBAI, UNITED ARAB EMIRATES – Media OutReach – 18 April 2023 – Bybit, the world’s third most visited crypto exchange with 15 million users worldwide, announced the grand opening of its global headquarters in Dubai today. The second largest crypto exchange in the Middle East and North Africa (MENA)1 also revealed future plans to elevate […]

LUXEMBOURG / ACCESSWIRE / April 17, 2023 / Moolec Science SA (NASDAQ:MLEC) (“Company”; “Moolec”), a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming, announced today it has entered into a Share Purchase Agreement (“Agreement”) with Nomura Securities International, Inc. (“Nomura”).The Agreement provides for a committed equity financing facility under […]

Rancho Santa Margarita, Calif., April 17, 2023 (GLOBE NEWSWIRE) — Global sweetness and flavor innovator, Sweegen announced today the launch of Sweetensify™ Flavors, its newest flavor tool for food and beverage producers, to create better-for-everyone products. Powered by Sweegen’s novel sweet protein technology that includes brazzein, thaumatin II, and other unique proteins, Sweetensify Flavors improve […]

Through an infusion of AI and evidence-based skin science, EveLab Insights secures its spot on The Silicon Review list. SINGAPORE / ACCESSWIRE / April 17, 2023 / EveLab Insight, a leading provider of AI-driven skin analysis services, has been named one of the top 5 AI companies to watch by The Silicon Review, a prominent platform for […]

HanchorBio Received IND Clearance of HCB101 Multi-regional Clinical Trial By US FDA TAIPEI, TAIWAN and SAN FRANCISCO, CA / ACCESSWIRE / April 17, 2023 / HanchorBio Inc., a global clinical-stage biotechnology company developing innovative immuno-biomedicines, announced today that the US. Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application to initiate […]